GlassScriptPhysician profile
Robert G Chandler
NPI 1316951486
$6,238.15
in general payments reported to CMS, 2019-2025
25 companies · $1,239 in 2025
The $1,239 reported for 2025 was more than what 77% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $781 · 2020: $168 · 2021: $682 · 2022: $759 · 2023: $2,081 · 2024: $529 · 2025: $1,239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,574 · Consulting Fee: $1,275.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,574.10 |
| Consulting Fee | $1,275.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Somavac Medical Solutions, INC. | $1,339.57 | 2023-2025 | Somavac 100 Sustained Vacuum System |
| Abbvie INC. | $1,092.57 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Alloderm, Botox |
| Allergan, INC. | $792.97 | 2019-2022 | |
| Mentor Worldwide LLC | $623.10 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Integra Lifesciences Corporation | $366.63 | 2022-2025 | Integra, Omnigraft, Integra Dermal Regeneration Template |
| Acera Surgical, INC. | $305.47 | 2019-2025 | Restrata Wound Matrix |
| Triad Life Sciences INC. | $255.28 | 2022 | |
| Sientra, INC. | $225.56 | 2019-2021 | |
| Smith+Nephew, INC. | $172.64 | 2019-2025 | Renasys Touch, Collagenase Santyl |
| Organogenesis INC. | $172.11 | 2019-2025 | Puraply Wound Matrix, Cygnus Dual, Novachor |
| Innovation Technologies INC | $169.16 | 2023-2025 | Irrisept |
| Rti Surgical, INC | $103.35 | 2025 | |
| Tela Bio, INC. | $99.27 | 2022-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Pacira Pharmaceuticals Incorporated | $98.74 | 2023-2024 | Exparel, Iovera |
| Aroa Biosurgery Incorporated | $87.38 | 2023 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Motiva USA, LLC | $56.00 | 2024-2025 | |
| Kci USA, INC. | $54.42 | 2019-2022 | |
| Musculoskeletal Transplant Foundation INC. | $50.71 | 2019-2025 | |
| Davol INC. | $45.23 | 2024-2025 | Arista Ah Flexitip, Arista |
| Sanara Medtech INC. | $40.04 | 2023-2024 | Celleraterx |
| Stryker Corporation | $25.62 | 2019 | |
| Solventum Corporation | $24.79 | 2025 | V.A.C.Ulta, Prevena |
| Acell, INC. | $13.46 | 2019 | |
| Medline Industries LP | $13.11 | 2022 | |
| Avanos Medical | $10.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Chandler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.